Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Ischemic Heart Disease

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 23 articles: HTML format

Single Articles

May 2025
1. LI J, Chen R, Zhao X, Liu C, et al
   Circulating and Regional Matrix Gla Protein Indicating Plaque Calcification and Prognosis of Patients with ST-Segment Elevation Myocardial Infarction.
   Thromb Haemost. 2025 May 23. doi: 10.1055/a-2599-9386.
   PubMed     Abstract available
   
   
   April 2025
2. SPAGNOLO M, Capodanno D
   Factor XI Inhibitors for Myocardial Infarction: A Safer Path to Thrombotic Protection?
   Thromb Haemost. 2025 Apr 25. doi: 10.1055/a-2593-1763.
   PubMed     Abstract available
   
   
   
3. VALERIANI E, Sesso HD, Pastori D, Menichelli D, et al
   Age related clinical efficacy of aspirin for primary cardiovascular prevention: a systematic-review and meta-analysis.
   Thromb Haemost. 2025 Apr 11. doi: 10.1055/a-2580-6931.
   PubMed     Abstract available
   
   
   March 2025
4. GOROG DA, Jeong YH
   Factor XI Measurement in Acute Coronary Syndrome.
   Thromb Haemost. 2025 Mar 31. doi: 10.1055/a-2546-2581.
   PubMed    
   
   
   February 2025
5. DUAN Y, Qiu M, Na K, Liu D, et al
   Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
   Thromb Haemost. 2025 Feb 4. doi: 10.1055/a-2531-3268.
   PubMed     Abstract available
   
   
   
6. ZHENG YY, Wu TT, Hou XG, Yang Y, et al
   Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study.
   Thromb Haemost. 2025;125:178-187.
   PubMed     Abstract available
   
   
   January 2025
7. SPAGNOLO M, Ammirabile N, Cutore L, Di Leo G, et al
   Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI.
   Thromb Haemost. 2025 Jan 27. doi: 10.1055/a-2525-4219.
   PubMed     Abstract available
   
   
   December 2024
8. JANG JY, Ga-In Y, Jongwha A, Bae JS, et al
   Optimal Long-term Antiplatelet Regimen for Patients with High Ischaemic and Bleeding Risks After Percutaneous Coronary Intervention.
   Thromb Haemost. 2024 Dec 10. doi: 10.1055/a-2499-5458.
   PubMed     Abstract available
   
   
   November 2024
9. SUAREZ A, Tobio-Parada U, Rodriguez-Carrio J, Martinez-Zapico A, et al
   Circulating levels of Low Density Granulocytes and cell-free DNA as predictors of cardiovascular disease and bone deterioration in SLE patients.
   Thromb Haemost. 2024 Nov 14. doi: 10.1055/a-2467-6826.
   PubMed     Abstract available
   
   
   
10. GU M, Xia N, Zhang S, Zhu X, et al
    Characterization of CD3+ T Lymphocytes in Human Coronary Thrombi with ST-segment Elevation Myocardial Infarction.
    Thromb Haemost. 2024 Nov 7. doi: 10.1055/a-2437-6111.
    PubMed     Abstract available
    
    
    October 2024
11. VAN DER SANGEN NMR, Azzahhafi J, Chan Pin Yin DRPP, Zaaijer LJG, et al
    Treatment Modifications in Acute Coronary Syndrome Patients Treated with Ticagrelor: Insights from the FORCE-ACS Registry.
    Thromb Haemost. 2024 Oct 29. doi: 10.1055/a-2421-8866.
    PubMed     Abstract available
    
    
    
12. GRAGNANO F, Angiolillo D
    Ticagrelor therapy modifications after acute coronary syndrome: An ever-evolving issue.
    Thromb Haemost. 2024 Oct 24. doi: 10.1055/a-2448-7029.
    PubMed     Abstract available
    
    
    
13. ASARE Y, Simsekyilmaz S, Kohncke J, Shagdarsuren G, et al
    Cardiac repair after myocardial infarction is controlled by a complement C5a receptor 1-driven signaling cascade.
    Thromb Haemost. 2024 Oct 4. doi: 10.1055/a-2434-4905.
    PubMed     Abstract available
    
    
    September 2024
14. GEISLER T
    Editorial : "Clinical impact of dyspnea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction".
    Thromb Haemost. 2024 Sep 23. doi: 10.1055/a-2420-0381.
    PubMed     Abstract available
    
    
    August 2024
15. KONSTANTINIDES SV
    Shifting Priorities in the Prevention of Venous Thromboembolism: Time to Focus on Overall Cardiovascular Health.
    Thromb Haemost. 2024 Aug 12. doi: 10.1055/s-0044-1788926.
    PubMed    
    
    
    June 2024
16. HRISTOV M, Weber C
    Monocyte subsets in cardiovascular disease: a biomarker perspective.
    Thromb Haemost. 2024 Jun 19. doi: 10.1055/a-2348-5697.
    PubMed     Abstract available
    
    
    
17. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    PubMed    
    
    
    
18. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    PubMed     Abstract available
    
    
    May 2024
19. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    PubMed     Abstract available
    
    
    April 2024
20. LIANG B, Zha L, Peng B, Chen Q, et al
    Association of Cardiovascular Health with the Incidence of Venous Thromboembolism: A Prospective Study of 275,149 Participants from the UK Biobank.
    Thromb Haemost. 2024 Apr 12. doi: 10.1055/a-2305-6631.
    PubMed     Abstract available
    
    
    
21. KIM SH, Shin S, Choo EH, Choi IJ, et al
    Clinical impact of dyspnoea after ticagrelor treatment and the effect of switching to clopidogrel in patients with myocardial infarction.
    Thromb Haemost. 2024 Apr 4. doi: 10.1055/a-2299-4537.
    PubMed     Abstract available
    
    
    March 2024
22. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    PubMed     Abstract available
    
    
    December 2023
23. YE Y, Hao Y, Zhao X, Liu J, et al
    Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.